To order this 500+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/digital-health-market/208.html
Key Inclusions
§
An overview of the
current market landscape of digital therapeutic solutions, including
information on status of development, type of solution (combination offering of software application + device or AI or personal
coach, and standalone software application), type of therapy (curative and preventive), purpose of
solution (medication
replacement and medication augmentation), target disease
indication(s), therapeutic area(s), and target population. In addition, it
presents details of the companies developing digital therapeutic solution,
highlighting year of establishment, company size, type of business model used (B2B and B2C) and location of
headquarters.
§
An in depth analysis
of the contemporary market trends, presented using four schematic
representations, including [A] a bubble analysis comparing the leading players
engaged in the development of digital therapeutic solutions based on the
parameters, such as product portfolio strength, number of target disease
indication(s) and company size, [B] a grid representation illustrating the
distribution of the digital therapeutic solutions based on status of
development, type of solution and therapeutic area, [C] an insightful tree map
representation of the digital therapeutic solutions, distributed on the basis
of therapeutic area and company size, and [D] a world map representation
highlighting the regional distribution of developer companies.
§ A detailed product competitiveness analysis of
digital therapeutic solutions developed / under development for the most
popular therapeutic areas taking into consideration the strength of product
portfolio (based on the total number of digital therapeutic solutions being
developed in that disease area) and key product specific parameters, such
as status of development, type of solution, type of therapy, and purpose of
solution.
§
Elaborate profiles of prominent
small-sized and mid-sized players that are either engaged in the development or
have developed digital therapeutic solutions. Each company profile features a
brief overview of the company (with information on year of establishment,
number of employees, location of headquarters and key members of the executive
team), details of their respective product portfolio, recent developments and
an informed future outlook.
§
A detailed analysis
of more than 220 completed, ongoing and planned clinical studies of various
digital therapeutic solutions, based on the various relevant parameters, such
as trial registration year, trial phase, number of patients enrolled, study
design, trial recruitment status and trial focus, highlighting leading sponsors
and leading digital therapeutic solutions (in
terms of number of trials conducted), type of organization, popular
therapeutic areas and regional distribution of trials. In addition, it features
an insightful clinical end-points analysis (for trials initiated since 2018
for popular therapeutic areas).
§
An analysis of the
investments made in the period between 2009 and 2020 (till June),
including seed financing, venture capital financing, debt financing, grants,
capital raised from IPOs and subsequent offerings, at various stages of
development in companies that are engaged in this field.
§
An analysis of the
partnerships that have been inked by stakeholders in this domain, in the period
between 2008 and 2020 (till May), covering clinical trial agreements,
pilot product offerings, product integration agreements, product launch
agreements, product / technology licensing agreements, marketing and
distribution agreements, mergers / acquisitions, and research and development
agreements.
§
A detailed analysis
of the various business models and go-to-market strategies adopted by companies
involved in this space, providing details on various channels adopted / being
adopted by stakeholders in the industry to raise awareness and offer access to
their proprietary products.
§
A Bowman’s Strategy
Clock framework in order to analyze the competitive position of various
companies in the marketplace, taking into consideration the prices and
different features of their products.
§
An insightful
discussion on the impact of COVID-19 pandemic on the overall digital
therapeutic solutions market, and the key initiatives undertaken by big pharma
players.
§
A review of the key
aspects related to the remote digital monitoring and diagnostics solutions,
including [A] a brief introduction to remote digital monitoring and diagnostics
solutions, highlighting the key benefits and roadblocks [B] an assessment of
the market landscape of remote digital monitoring and diagnostics solutions,
based on various parameters, such as status of development, type of solution,
target disease indication(s) and therapeutic area, along with details on the
companies that develop these solutions, highlighting year of establishment,
company size and location of headquarters [C] detailed profiles of some of the
key players that presently offer digital monitoring / diagnostic solutions for
chronic disease management; each profile features a brief overview of the
company (with information on year of
establishment, number of employees, location of headquarters, lead investors,
key partners and members of the
executive team), details of their product portfolio, recent developments
and an informed future outlook, and [D] an insightful analysis on various
capital investments that have been made into the digital monitoring /
diagnostics domain.
§
A discussion on
affiliated trends, key drivers and challenges, under a SWOT framework, which
are likely to impact the industry’s evolution, including a Harvey ball
analysis, highlighting the relative effect of each SWOT parameter on the
overall digital therapeutic solutions industry.
§
An informative
analysis of contemporary Google Trends in the time period between 2015 and 2020
(till July) and insights from the recent news articles related digital
therapeutic solutions, indicating the increasing popularity of this domain.
Furthermore, it highlights the potential future opportunities for players
engaged in development of such solutions.
The report also features the likely
distribution of the current and forecasted opportunity across important market
segments, mentioned below:
§ Type
of Solution
§
Standalone Software Application
§
Software Application + Device + Personal Coach
§
Software Application + Device + AI Support
§
Software Application + Device
§
Software Application + AI Support
§
Software Application + Personal Coach
§
Other Types of Solutions
§ Purpose
of Solution
§ Medication
Replacement
§ Medication
Augmentation
§ Type
of Therapy
§ Curative
§ Preventive
§ Business
Model
§ Business
to Consumer (Patients and Caregivers)
§ Business
to Business (Healthcare Providers, Payers, Employers and
Pharmaceutical Companies)
§ Therapeutic
Areas
§ Cardiovascular
Disorders
§ Chronic
Pain
§ Mental
Health Problems
§ Metabolic
Disorders
§ Neurological
Disorders
§ Respiratory
Disorders
§ Sleep
Disorders
§ Substance
Use Disorders
§ Others
§ Key
Geographical Regions
§ North
America
§ Europe
§ Asia-Pacific
§ Rest
of the world
The report includes
detailed transcripts of discussions held with the following experts:
§ Eran
Ofir (Co-Founder and Chief Executive Officer, Somatix)
§ Edouard
Gasser (Co-Founder and Chief Executive Officer, Tilak Healthcare)
§ Stephanie
Tilenius (Co-Founder and Chief Executive Officer, Vida Health)
§ Adam
Kaufman (Chief
Executive Officer, Canary
Health)
§ Vijay
Ravindran (Chief
Executive Officer, Floreo)
§ Palakh
R Sarogi (Vice President, Marketing, Wellthy Therapeutics),
Arani Sarkra (Senior Manager, Consumer Marketing, Wellthy Therapeutics)
and Yolande D’Mello (Marketing and Public Relations, Wellthy Therapeutics)
§ Amelie
Janson (Communication Manager, Voluntis)
§ Anonymous
(Founder and Chief Executive Officer, UK based Small-sized Company)
To request sample pages, please visit this - https://www.rootsanalysis.com/reports/208/request-sample.html
Key Questions Answered
§ Who are the leading developers offering
digital therapeutic solutions?
§ What are the most popular therapeutic areas
for digital therapeutic solutions?
§ Which companies are actively involved in
conducting clinical trials for their solutions?
§ What are the key factors influencing the price
of digital therapeutic solutions?
§ What is the trend in capital investments in
the digital therapeutics market?
§ Which partnership models are commonly adopted
by stakeholders in this industry?
§ What type of marketing strategies are being
adopted by developers in this domain?
§ What is the impact of COVID-19 outbreak on
digital therapeutic solutions market?
§ What are the opportunities for digital
therapeutic solutions in emerging markets?
§ How is the current and future opportunity
likely to be distributed across key market segments?
§ What are the anticipated future trends related
to digital therapeutic solutions market?
You may also be
interested in the following titles:
1.
AR /
VR Based Healthcare Digital Marketing Service Providers
Market, 2020-2030
2.
AI-Based
Clinical Trial Solution Providers Market, 2020-2030
3.
Global
Handheld Ultrasound Imaging Devices Market, 2020-2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
